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iDITORIAL COMMENT
ostconditioning
ld Wine in a New Bottle?*
erd Heusch, MD, FESC, FACC
ssen, Germany
nfarct size is the decisive determinant of the extent and
everity of remodeling (1) and of the prognosis of patients
fter myocardial infarction (2). Timely reperfusion is the
nly way to reduce ultimate infarct size. However, reperfu-
ion comes at a price and induces injury per se. The
mmediate and full restoration of coronary blood flow
esults in arrhythmias, contractile dysfunction (stunning),
nd microvascular impairment. Although previously de-
ated (3,4), it is now clear that there also is irreversible
eperfusion injury through apoptosis and necrosis (5,6). The
echanisms of reperfusion injury relate to the excess for-
ation of free radicals (7), to calcium overload, and finally
o hypercontracture (6,8).
See page 1103
To attenuate reperfusion injury, staged/controlled reper-
usion with retarded restoration of full coronary blood flow
nd perfusion pressure (9–11) or modification of the reper-
usate (e.g., maintenance of acidic pH [12], inhibition of
odium-calcium exchange [13], contractile blockade [14],
ddition of antioxidants [15]), has been proposed for many
ears. Recently, the pharmacologic activation of reperfusion
njury salvage kinase (RISK) pathways also has been docu-
ented to attenuate irreversible reperfusion injury (16).
ow and where in the signal transduction cascade the
arious maneuvers to attenuate reperfusion injury converge
echanistically, remains to be defined.
Preconditioning does not reduce ultimate infarct size but
elays the development of infarction so that with timely
eperfusion, the actual infarct size is reduced. Precondition-
ng has provided a powerful paradigm for the experimental
nalysis of the signal transduction cascade (17), both of
ardiomyocyte death and protection from it. However, the
linical exploitation of the preconditioning phenomenon
as been rather disappointing thus far (18), largely because
reconditioning must be instituted briefly before an isch-
mic event, which is not possible in daily life, and also because
n cardiac surgery, where it would be feasible, alternative
owerful protective interventions are already being used (e.g.,
pioids, inhalation anesthetics, cardioplegia).
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Institut für Pathophysiologie, Zentrum für Innere Medizin, Univer-witätsklinikum Essen, Essen, Germany.Postconditioning was originally described by Zhao et al.
19) as the reduction of infarct size by several cycles of
oronary occlusion/reperfusion after a sustained ischemic
nsult in dogs and subsequently in rats (20). The catchy term
postconditioning,” which refers to preconditioning and
mplies likewise an underlying signal transduction cascade,
ppears justified because a very similar protocol of brief
ycles of ischemia/reperfusion is used following, rather than
receding (as in preconditioning), a sustained ischemic
nsult. However, this does not exclude that postconditioning
s merely an easy and effective method of staged/controlled
eperfusion (see the preceding text). Again, the mechanistic
elationships of staged reperfusion maneuvers, the activation
f reperfusion salvage kinase pathways, and the complex
ignal transduction cascade of preconditioning need to be
efined in detail.
In this issue of the Journal, Yang et al. (21) confirm the
riginal observation of postconditioning in another species
i.e., rabbits), and then carefully define the magnitude and
ime frame of the observed protection with triphenyltetra-
olium chloride staining of infarct size as a robust end point.
he reduction in infarct size under these controlled condi-
ions, consistent with the original previous study by Zhao et
l. (19) in dogs, is indeed impressive, i.e., by approximately
0%, albeit somewhat less than with preconditioning. Im-
ortantly, the authors proceed to identify the signaling
lements of postconditioning that are shared by precondi-
ioning (i.e., the KATP-channel) (17) and those that are
ossibly different from those of preconditioning but are
hared by the reperfusion salvage kinase pathway (i.e.,
xtracellular signal-regulated kinases) (16) by use of selec-
ive antagonists. The analysis of signal transduction in
ostconditioning will require more studies, particularly in
arger mammals that sometimes differ in that respect from
odents but are closer to humans (17).
In contrast to preconditioning, postconditioning appears
o be easily feasible in patients with impending acute
yocardial infarction who undergo interventional reperfu-
ion. Of course, the potential of postconditioning must be
igorously tested in clinical trials, first for its safety and
easibility and then subsequently for its efficacy and thera-
eutic potential. It will be mandatory in such clinical trials
o carefully control for confounding variables—as done in
he above experimental studies—such as the size of the area
t risk, the duration of the preceding ischemic insult, and
ollateral status. Neglect of these confounding variables has
robably contributed to the failure of translation of exper-
mentally validated principles of cardioprotection to the
linical arena (e.g., adenosine receptor activation, sodium-
roton exchange inhibition) in the past.
In conclusion, to answer the hypothetical question posed
n the title of this comment, postconditioning is possibly an
ld wine (i.e., staged reperfusion), but a very good one, and
t comes in a very practical new bottle that may facilitate its
idespread distribution.
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